/
GDRX
$2.86+$0.06 (+2.14%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$948.3M
339M shares
52-week range
$1.77 – $5.81
27% from low
Sector
SERVICES-COMPUTER PROCESSING & DATA PREPARATION
Exchange
NASDAQ
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-33.15
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $249.5M | $388.2M | $550.7M | $745.4M | $766.6M | $750.3M | $792.3M | $796.9M |
| Cost of revenue | $6.0M | $14.0M | $29.6M | $46.7M | $65.1M | $66.9M | $48.2M | $57.6M |
| Gross profit | $243.5M | $374.2M | $521.1M | $698.7M | $701.5M | $683.3M | $744.1M | $739.3M |
| Gross margin | 97.6% | 96.4% | 94.6% | 93.7% | 91.5% | 91.1% | 93.9% | 92.8% |
| R&D | $43.9M | $29.3M | $61.8M | $125.9M | $143.1M | $135.8M | $123.7M | $121.0M |
| Operating income | $77.3M | $139.7M | −$275.7M | $13.4M | $1.7M | −$27.0M | $65.8M | $87.5M |
| EBITDA | $84.3M | $146.1M | −$257.1M | $48.0M | $65.2M | $108.8M | $153.9M | $184.4M |
| Net income | $43.8M | $66.0M | −$293.6M | −$25.3M | −$32.8M | −$8.9M | $16.4M | $30.4M |
| Net margin | 17.6% | 17.0% | -53.3% | -3.4% | -4.3% | -1.2% | 2.1% | 3.8% |
| EPS (diluted) | 0.12 | 0.12 | -1.07 | -0.06 | -0.08 | -0.02 | 0.04 | 0.09 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $776M | $0.31 | $0.29–$0.35 | 8 |
| 2027 | $819M | $0.36 | $0.31–$0.45 | 8 |
| 2028 | $882M | $0.43 | $0.13–$0.77 | 7 |
| 2029 | $978M | $0.70 | $0.69–$0.72 | 2 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$5.89
Price
$2.86
Implied upside
+106%
Peer comparison
GoodRx Holdings, Inc. Class A Common Stock
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
www.goodrx.com- Employees
- 697
- IPO / List date
- Sep 23, 2020
- HQ
- SANTA MONICA, CA
Held by traders on TradeandTell
No one on the platform currently holds GDRX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 3,259,738 | $6.4M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GDRX yet.
